| Product NDC: | 0173-0699 |
| Proprietary Name: | LAMICTAL |
| Non Proprietary Name: | lamotrigine |
| Active Ingredient(s): | 2 mg/1 & nbsp; lamotrigine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, CHEWABLE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0173-0699 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020764 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20001012 |
| Package NDC: | 0173-0699-02 |
| Package Description: | 30 TABLET, CHEWABLE in 1 BOTTLE (0173-0699-02) |
| NDC Code | 0173-0699-02 |
| Proprietary Name | LAMICTAL |
| Package Description | 30 TABLET, CHEWABLE in 1 BOTTLE (0173-0699-02) |
| Product NDC | 0173-0699 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lamotrigine |
| Dosage Form Name | TABLET, CHEWABLE |
| Route Name | ORAL |
| Start Marketing Date | 20001012 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | LAMOTRIGINE |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |